GLP-1 Binding The EM structure of the GLP-1 apo receptor (i.e., receptor in the absence of any ligand), shows that the N-terminal domain adopts a closed or inactive conformation, where a cap-like structure blocks access to the peptide binding ( PDB ID 6ln2, Wu et al., 2020, Figure 4a)
these include decreases in liver fat, decreases in glycated hemoglobin, and improvements in lipid profiles
TL;DR Eating less overall shrinks the opportunity to meet your bodys needs
It is known to lower the risks of heart disease by improving cholesterol levels in the blood, thereby protecting against the possibility of stroke and high blood pressure
The American Diabetes Association (ADA) recommends [archived link] GLP-1 RAs as first-choice Type 2 diabetes medication options in many cases